| Literature DB >> 17716683 |
Steven R Fauce1, Otto O Yang, Rita B Effros.
Abstract
During HIV-1 infection, the CD8(+) T lymphocyte response is critical to controlling the virus; indeed, the development of AIDS results, in large part, from the eventual failure of this response. The ability to measure the composite CD8(+) T lymphocyte anti-viral activity is, therefore, an essential requirement in the evaluation of immune based therapies and potential vaccines. We report here the details of a reproducible assay that measures the ability of CD8(+) T lymphocytes to suppress viral production by infected autologous CD4(+) T lymphocytes. The assay is not limited to persons with any specific HLA type, and the use of bi-specific antibodies for cell expansion makes the assay feasible in situations where cell numbers may be limiting. The measurement of viral production over time provides a global readout of the CD8(+) T lymphocyte overall function against HIV-1, which can be used for longitudinal assessment of individual HIV-infected persons in order to evaluate therapy, immune reconstitution, and new vaccines.Entities:
Mesh:
Year: 2007 PMID: 17716683 PMCID: PMC2151928 DOI: 10.1016/j.jim.2007.07.017
Source DB: PubMed Journal: J Immunol Methods ISSN: 0022-1759 Impact factor: 2.303